114 related articles for article (PubMed ID: 8068726)
21. Comparative effects of two HMG-CoA reductase inhibitors (lovastatin and pravastatin) on serum lipids and lipoproteins.
Richter WO; Jacob BG; Schwandt P
Int J Tissue React; 1991; 13(2):107-10. PubMed ID: 1955291
[TBL] [Abstract][Full Text] [Related]
22. Hepatic and nonhepatic sterol synthesis and tissue distribution following administration of a liver selective HMG-CoA reductase inhibitor, CI-981: comparison with selected HMG-CoA reductase inhibitors.
Bocan TM; Ferguson E; McNally W; Uhlendorf PD; Bak Mueller S; Dehart P; Sliskovic DR; Roth BD; Krause BR; Newton RS
Biochim Biophys Acta; 1992 Jan; 1123(2):133-44. PubMed ID: 1739744
[TBL] [Abstract][Full Text] [Related]
23. Farnesol is not the nonsterol regulator mediating degradation of HMG-CoA reductase in rat liver.
Keller RK; Zhao Z; Chambers C; Ness GC
Arch Biochem Biophys; 1996 Apr; 328(2):324-30. PubMed ID: 8645011
[TBL] [Abstract][Full Text] [Related]
24. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs.
Davis HR; Pula KK; Alton KB; Burrier RE; Watkins RW
Metabolism; 2001 Oct; 50(10):1234-41. PubMed ID: 11586500
[TBL] [Abstract][Full Text] [Related]
25. Triacylglycerol metabolism in the phenobarbital-treated rat.
Goldberg DM; Roomi MW; Yu A; Roncari DA
Biochem J; 1981 Apr; 196(1):337-46. PubMed ID: 7306075
[TBL] [Abstract][Full Text] [Related]
26. Enhancement of fatty acid and cholesterol synthesis accompanied by enhanced biliary but not very-low-density lipoprotein lipid secretion following sustained pravastatin blockade of hydroxymethyl glutaryl coenzyme A reductase in rat liver.
Carrella M; Fong LG; Loguercio C; Del Piano C
Metabolism; 1999 May; 48(5):618-26. PubMed ID: 10337863
[TBL] [Abstract][Full Text] [Related]
27. Cinnamate supplementation enhances hepatic lipid metabolism and antioxidant defense systems in high cholesterol-fed rats.
Lee JS; Jeon SM; Park EM; Huh TL; Kwon OS; Lee MK; Choi MS
J Med Food; 2003; 6(3):183-91. PubMed ID: 14585184
[TBL] [Abstract][Full Text] [Related]
28. The mechanism of lack of hypocholesterolemic effects of pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in rats.
Fujioka T; Nara F; Tsujita Y; Fukushige J; Fukami M; Kuroda M
Biochim Biophys Acta; 1995 Jan; 1254(1):7-12. PubMed ID: 7811749
[TBL] [Abstract][Full Text] [Related]
29. Regulation of early cholesterol biosynthesis in rat liver: effects of sterols, bile acids, lovastatin, and BM 15.766 on 3-hydroxy-3-methylglutaryl coenzyme A synthase and acetoacetyl coenzyme A thiolase activities.
Honda A; Salen G; Nguyen LB; Xu G; Tint GS; Batta AK; Shefer S
Hepatology; 1998 Jan; 27(1):154-9. PubMed ID: 9425931
[TBL] [Abstract][Full Text] [Related]
30. Long-chain fatty acids and their acyl-CoA esters cause the translocation of phosphatidate phosphohydrolase from the cytosolic to the microsomal fraction of rat liver.
Martin-Sanz P; Hopewell R; Brindley DN
FEBS Lett; 1984 Oct; 175(2):284-8. PubMed ID: 6090213
[TBL] [Abstract][Full Text] [Related]
31. Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol.
Reihnér E; Rudling M; Ståhlberg D; Berglund L; Ewerth S; Björkhem I; Einarsson K; Angelin B
N Engl J Med; 1990 Jul; 323(4):224-8. PubMed ID: 2114543
[TBL] [Abstract][Full Text] [Related]
32. Bile acid derived HMG-CoA reductase inhibitors.
Kramer W; Wess G; Enhsen A; Bock K; Falk E; Hoffmann A; Neckermann G; Gantz D; Schulz S; Nickau L
Biochim Biophys Acta; 1994 Nov; 1227(3):137-54. PubMed ID: 7986821
[TBL] [Abstract][Full Text] [Related]
33. Comparative effects of dietary fish oil and carbohydrate on plasma lipids and hepatic activities of phosphatidate phosphohydrolase, diacylglycerol acyltransferase and neutral lipase activities in the rat.
Marsh JB; Topping DL; Nestel PJ
Biochim Biophys Acta; 1987 Nov; 922(2):239-43. PubMed ID: 2823908
[TBL] [Abstract][Full Text] [Related]
34. Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia.
Hsu I; Spinler SA; Johnson NE
Ann Pharmacother; 1995; 29(7-8):743-59. PubMed ID: 8520093
[TBL] [Abstract][Full Text] [Related]
35. Tissue-selective inhibition of sterol synthesis in mice by pravastatin sodium after a single or repeated oral administrations.
Koga T; Kikuchi T; Miyazaki A; Koike H
Lipids; 1995 Aug; 30(8):775-9. PubMed ID: 7475995
[TBL] [Abstract][Full Text] [Related]
36. Lymphatic transport of cholesterol in normocholesterolemic rats treated with pravastatin, an inhibitor of HMG-CoA reductase.
Sakono M; Ibi T; Nagao K; Ikeda I; Yamamoto K; Imaizumi K
Atherosclerosis; 1996 Jul; 124(1):95-102. PubMed ID: 8800497
[TBL] [Abstract][Full Text] [Related]
37. Aging promotes a different phosphatidic acid utilization in cytosolic and microsomal fractions from brain and liver.
Pasquaré SJ; Ilincheta de Boschero MG; Giusto NM
Exp Gerontol; 2001 Aug; 36(8):1387-401. PubMed ID: 11602212
[TBL] [Abstract][Full Text] [Related]
38. A rapid assay for measuring the activity and the Mg2+ and Ca2+ requirements of phosphatidate phosphohydrolase in cytosolic and microsomal fractions of rat liver.
Martin A; Hales P; Brindley DN
Biochem J; 1987 Jul; 245(2):347-55. PubMed ID: 2822021
[TBL] [Abstract][Full Text] [Related]
39. Spermine promotes the translocation of phosphatidate phosphohydrolase from the cytosol to the microsomal fraction of rat liver and it enhances the effects of oleate in this respect.
Martin-Sanz P; Hopewell R; Brindley DN
FEBS Lett; 1985 Jan; 179(2):262-6. PubMed ID: 2981704
[TBL] [Abstract][Full Text] [Related]
40. Influence of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on mitochondrial respiration in rat liver during ischemia.
Satoh K; Nakai T; Ichihara K
Eur J Pharmacol; 1994 Aug; 270(4):365-9. PubMed ID: 7805787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
